Elevance Health(ELV) - 2022 Q4 - Earnings Call Transcript

Elevance Health's SG&A expense ratio in the fourth quarter was 11.5% and 11.4% for the full year reflecting an improvement of 20 basis points in the fourth quarter and full year. These positive results include the negative impact on the SG&A ratio related to aligning certain quality improvement expenses with CMS guidelines. The overall improvement was driven primarily by expense leverage associated with strong growth in operating revenue. Elevance Health Inc. (NYSE:ELV) Q4 2022 Earnings Conference Call Janu ...